Fast-growing Apohem continues to expand and gain market share, now strengthening with a renowned board. Eivor Andersson assumes the role of new chairman of the board, and Emma Stjernlöf and Marina Davarinou as board members during the last quarter of 2022.
.png)
Apohem is a challenger in the pharmacy industry and the fastest-growing online pharmacy, with a growth rate of 76 percent during the first half of the year. Now, Apohem takes another step in its growth journey by reinforcing the board with three heavyweight recruitments.
Eivor Andersson assumes the role of chairman of the board for Apohem, sits on the boards of Svenska Spel, First Camp, and MEKO (Mekonomen), and has previously served as chairman of the board for Skistar. She has over 30 years of experience in the experience industry, including as CEO of Ving and Group CEO of TUI Nordic.
"Apohem's growth journey is impressive, and the company is now entering an exciting phase where new demands are placed on scalability, processes, and organization. I look forward to working with the board and CEO and contributing my experiences in building companies," says Eivor Andersson.
New board members Emma Stjernlöf and Marina Davarinou are also appointed. Emma Stjernlöf has many years of experience in PR, communications, and brand work from roles such as brand director for Adidas and Nordic communications director for Google. Since 2020, she has been CEO of the fitness brand Röhnisch. Marina Davarinou has extensive experience in e-commerce from roles such as marketing director for Netonnet and CEO of Ellos. Since 2021, Marina Davarinou has been COO of the children's and baby e-commerce company Jollyroom.
"Differentiation is needed in the pharmacy industry, and Apohem is on a branding journey that stands out and takes charge. I am passionate about strong brands and look forward to contributing to the work of putting Apohem on the map," says Emma Stjernlöf.
"Apohem is a very exciting company that has succeeded in challenging the pharmacy industry with fantastic growth. I am impressed by the organization's drive and commitment, and I look forward to being part of Apohem's board and supporting the company and organization," says Marina Davarinou.
"Apohem continues to grow rapidly and continues to invest in, among other things, technology, logistics, brand awareness, and organization. I look forward to working with Eivor, Emma, and Marina," says Gustav Hasselgren, CEO of Apohem.
Previously, Jonas Hedman, responsible for investments at Novax, and Carl Stenbeck, strategy and business development director at Axfood, sit on the board of Apohem.
For further information, please contact:
Gustav Hasselgren, CEO Apohem, gustav.hasselgren@apohem.se
Magnus Törnblom, Press Manager Axfood, 070-266 27 12, magnus.tornblom@axfood.se
The online pharmacy Apohem is a health and beauty destination that aims to make life easy through inspiration, knowledge, and products. The company is part of the Axel Johnson Group, owned by Axfood and Novax, and has been a full-scale open healthcare pharmacy since 2019, offering both over-the-counter and prescription medicines. In addition to a wide range of over 15,000 products, Apohem offers personal service and advice from licensed pharmacists and skincare therapists, as well as professional customer advisors.
